1 not yet recruiting, 1 recruiting, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Cancer of Kidney: new trials by email Literature Review of Cancer of Kidney trials Research Report on Cancer of Kidney
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder Psilocybin therapy - Adjustment Disorder, Adjustment Disorder With Anxious Mood | Phase 2 | Recruiting | Psyence Australia Pty Ltd | 87 | 2025-10-01 | 2026-10-29 |
| Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients Cabozantinib, Blood sample, Questionnaires of quality of life - Cancer of Kidney | Phase 2 | Not yet recruiting | Centre Hospitalier Universitaire de Besancon | 24 | 2022-06-01 | 2022-06-01 |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors MEDI4736 - Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Phase 2 | Terminated | Washington University School of Medicine | 4 | 2016-09-12 | 2018-11-06 |
Kidney Neoplasms (3) · Breast Neoplasms (2) · Pancreatic Neoplasms (2) · Adjustment Disorders (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Melanoma (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Urologic Diseases (3) · Urologic Neoplasms (3) · Breast Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Gastrointestinal Diseases (2)
Blood Specimen Collection (1) · cabozantinib (1) · durvalumab (1)
Centre Hospitalier Universitaire de Besancon (1) · Psyence Australia Pty Ltd (1) · Washington University School of Medicine (1)
Australia (1) · France (1) · United States (1)
Neil Maresky (1) · Ramaswamy Govindan, M.D. (1)